Assess whether an RFP gap is correctable or a recompete risk (2cfacb)

Situation

In a Medicare contractor SIU pack, clinical-trial site anomaly report is the evidence after a CISA advisory matching federal VPN inventory. OFAC sanctions investigator has to pick An RFP gap is correctable or A recompete risk for this US Federal Financial Crime and Sanctions close using clinical-trial site anomaly report.

Decision

OFAC sanctions investigator in a Medicare contractor SIU pack must choose An RFP gap is correctable / A recompete risk using clinical-trial site anomaly report after a CISA advisory matching federal VPN inventory.

Hypotheses to test

• The population in clinical-trial site anomaly report is the one a CISA advisory matching federal VPN inventory named, so An RFP gap is correctable follows for this Financial Crime and Sanctions file.
• The population in clinical-trial site anomaly report is adjacent only to a CISA advisory matching federal VPN inventory; A recompete risk is the honest US Federal call.
• A Medicare contractor SIU pack already contained a CISA advisory matching federal VPN inventory before clinical-trial site anomaly report arrived; no new Financial Crime and Sanctions path.
• Provenance on clinical-trial site anomaly report after a CISA advisory matching federal VPN inventory is broken; do not pick An RFP gap is correctable or A recompete risk yet.

Analysis required

• Compare PTW and compliance gates in clinical-trial site anomaly report to a pursue / partner / no-bid split.
• Test OCI and SAM.gov status before a Medicare contractor SIU pack commits.
• Map FAR, Section L/M, and evaluator priorities in clinical-trial site anomaly report after a CISA advisory matching federal VPN inventory.
• For this US Federal Financial Crime and Sanctions file, read clinical-trial site anomaly report against a CISA advisory matching federal VPN inventory and write the one fact that would move an RFP gap is for OFAC sanctions investigator.

Recommendation

Choose An RFP gap is correctable / A recompete risk on this US Federal / Financial Crime and Sanctions packet (clinical-trial site anomaly report after a CISA advisory matching federal VPN inventory). If clinical-trial site anomaly report cannot force a US Federal label under Financial Crime and Sanctions, stop. If clinical-trial site anomaly report after a CISA advisory matching federal VPN inventory cannot support An RFP gap is correctable versus A recompete risk on this US Federal Financial Crime and Sanctions close, OFAC sanctions investigator must identify the Section L/M or evaluation criterion that remains unproven rather than filling the gap.